329 related articles for article (PubMed ID: 17485514)
1. The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation.
McCarthy C; Shepherd D; Fleire S; Stronge VS; Koch M; Illarionov PA; Bossi G; Salio M; Denkberg G; Reddington F; Tarlton A; Reddy BG; Schmidt RR; Reiter Y; Griffiths GM; van der Merwe PA; Besra GS; Jones EY; Batista FD; Cerundolo V
J Exp Med; 2007 May; 204(5):1131-44. PubMed ID: 17485514
[TBL] [Abstract][Full Text] [Related]
2. Phage display-derived recombinant antibodies with TCR-like specificity against alpha-galactosylceramide and its analogues in complex with human CD1d molecules.
Denkberg G; Stronge VS; Zahavi E; Pittoni P; Oren R; Shepherd D; Salio M; McCarthy C; Illarionov PA; van der Merwe A; Besra GS; Dellabona P; Casorati G; Cerundolo V; Reiter Y
Eur J Immunol; 2008 Mar; 38(3):829-40. PubMed ID: 18253930
[TBL] [Abstract][Full Text] [Related]
3. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
4. The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex.
Sidobre S; Naidenko OV; Sim BC; Gascoigne NR; Garcia KC; Kronenberg M
J Immunol; 2002 Aug; 169(3):1340-8. PubMed ID: 12133957
[TBL] [Abstract][Full Text] [Related]
5. Antigen specificity of semi-invariant CD1d-restricted T cell receptors: the best of both worlds?
Gumperz JE
Immunol Cell Biol; 2004 Jun; 82(3):285-94. PubMed ID: 15186260
[TBL] [Abstract][Full Text] [Related]
6. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
[TBL] [Abstract][Full Text] [Related]
7. A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR.
Wun KS; Borg NA; Kjer-Nielsen L; Beddoe T; Koh R; Richardson SK; Thakur M; Howell AR; Scott-Browne JP; Gapin L; Godfrey DI; McCluskey J; Rossjohn J
J Exp Med; 2008 Apr; 205(4):939-49. PubMed ID: 18378792
[TBL] [Abstract][Full Text] [Related]
8. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
[TBL] [Abstract][Full Text] [Related]
9. Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells.
Silk JD; Salio M; Reddy BG; Shepherd D; Gileadi U; Brown J; Masri SH; Polzella P; Ritter G; Besra GS; Jones EY; Schmidt RR; Cerundolo V
J Immunol; 2008 May; 180(10):6452-6. PubMed ID: 18453560
[TBL] [Abstract][Full Text] [Related]
10. Conservation of molecular and cellular phenotypes of invariant NKT cells between humans and non-human primates.
Yu KKQ; Wilburn DB; Hackney JA; Darrah PA; Foulds KE; James CA; Smith MT; Jing L; Seder RA; Roederer M; Koelle DM; Swanson WJ; Seshadri C
Immunogenetics; 2019 Jul; 71(7):465-478. PubMed ID: 31123763
[TBL] [Abstract][Full Text] [Related]
11. CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells.
Thedrez A; de Lalla C; Allain S; Zaccagnino L; Sidobre S; Garavaglia C; Borsellino G; Dellabona P; Bonneville M; Scotet E; Casorati G
Blood; 2007 Jul; 110(1):251-8. PubMed ID: 17363727
[TBL] [Abstract][Full Text] [Related]
12. NKT TCR recognition of CD1d-α-C-galactosylceramide.
Patel O; Cameron G; Pellicci DG; Liu Z; Byun HS; Beddoe T; McCluskey J; Franck RW; Castaño AR; Harrak Y; Llebaria A; Bittman R; Porcelli SA; Godfrey DI; Rossjohn J
J Immunol; 2011 Nov; 187(9):4705-13. PubMed ID: 21964029
[TBL] [Abstract][Full Text] [Related]
13. Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors.
Brigl M; van den Elzen P; Chen X; Meyers JH; Wu D; Wong CH; Reddington F; Illarianov PA; Besra GS; Brenner MB; Gumperz JE
J Immunol; 2006 Mar; 176(6):3625-34. PubMed ID: 16517731
[TBL] [Abstract][Full Text] [Related]
14. Structural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands.
Schiefner A; Fujio M; Wu D; Wong CH; Wilson IA
J Mol Biol; 2009 Nov; 394(1):71-82. PubMed ID: 19732779
[TBL] [Abstract][Full Text] [Related]
15. Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand alpha-galactosylceramide bound to mouse CD1d.
Yu KO; Im JS; Illarionov PA; Ndonye RM; Howell AR; Besra GS; Porcelli SA
J Immunol Methods; 2007 May; 323(1):11-23. PubMed ID: 17442335
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: influence of the TCR V beta domain on the avidity of CD1d:alpha-galactosylceramide binding by invariant V alpha 14 NKT cells.
Schümann J; Voyle RB; Wei BY; MacDonald HR
J Immunol; 2003 Jun; 170(12):5815-9. PubMed ID: 12794105
[TBL] [Abstract][Full Text] [Related]
17. Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts.
Lang GA; Maltsev SD; Besra GS; Lang ML
Immunology; 2004 Jul; 112(3):386-96. PubMed ID: 15196206
[TBL] [Abstract][Full Text] [Related]
18. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.
Borg NA; Wun KS; Kjer-Nielsen L; Wilce MC; Pellicci DG; Koh R; Besra GS; Bharadwaj M; Godfrey DI; McCluskey J; Rossjohn J
Nature; 2007 Jul; 448(7149):44-9. PubMed ID: 17581592
[TBL] [Abstract][Full Text] [Related]
19. The paradox of immune molecular recognition of alpha-galactosylceramide: low affinity, low specificity for CD1d, high affinity for alpha beta TCRs.
Cantu C; Benlagha K; Savage PB; Bendelac A; Teyton L
J Immunol; 2003 May; 170(9):4673-82. PubMed ID: 12707346
[TBL] [Abstract][Full Text] [Related]
20. Critical role for CD1d-restricted invariant NKT cells in stimulating intrahepatic CD8 T-cell responses to liver antigen.
Sprengers D; Sillé FC; Derkow K; Besra GS; Janssen HL; Schott E; Boes M
Gastroenterology; 2008 Jun; 134(7):2132-43. PubMed ID: 18549881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]